Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

8,439 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,769
Recruiting: 1,009
Ph III recruiting: 99
Growth YoY: −2.8%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 35.6%
Trials / 1,000 deaths: 75 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,350)

clinicaltrialsPublishedShowing 601–650 of 8,439 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02071901	Eltrombopag Olamine in Improving Platelet Recovery in Older Patients With Acute Myeloid Leukemia Undergoing Chemotherapy	completed	Phase 2	31	Case Comprehensive Cancer CenterOTHER	1	Aug 7, 2026	clinicaltrials
NCT03504644	Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia	active not recruiting	Phase 1 / Phase 2	40	ECOG-ACRIN Cancer Research GroupNETWORK	2	Aug 7, 2026